Clinical trial
Efficacy of Alternate Dupilumab Schedule in Recurrent Chronic Rhinosinusitis With Nasal Polyposis Patients
NCT06750471 is registered in ClinicalTrials.gov with Madigan Army Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Alternate Dupilumab Schedule in Recurrent Chronic Rhinosinusitis With Nasal Polyposis Patients
- Lead sponsor
- Madigan Army Medical Center
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- October 14, 2021
- Completion date
- December 31, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.